Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Three apoptotic genes are upregulated in a patient with Alzheimer's disease and well-differentiated squamous cell carcinoma.

Salemi M, Giuffrida D, Giuffrida MC, Soma PF, La Vignera S, Cimino L, Condorelli RA, Romano C, Bosco P, Vicari LO, Calogero AE.

Int J Biol Markers. 2012 Jan-Mar;27(1):60-3. doi: 10.5301/JBM.2012.8991.

PMID:
22307387
2.

CASP3 and LDOC-1 gene expression in a patient with carcinoma in the hairy part of the head skin and Alzheimer disease.

Salemi M, Soma PF, Bosco P, Vicari E, Castiglione R, Calogero AE.

Hum Cell. 2013 Sep;26(3):128-30. doi: 10.1007/s13577-012-0052-5. Epub 2013 Jun 18. No abstract available. Erratum in: Hum Cell. 2013 Sep;26(3):131. Roberto, Castiglione [corrected to Castiglione, Roberto].

PMID:
23775301
3.

LDOC1 gene expression in two patients with head and neck squamous cell carcinomas and Parkinson's disease.

Salemi M, Giuffrida D, Giuffrida MC, Soma PF, Rolfo A, Cimino L, Condorelli RA, Castiglione R, La Vignera S, Calogero AE.

Tumori. 2012 May-Jun;98(3):86e-88e. doi: 10.1700/1125.12418.

PMID:
22825526
4.

Two proapoptotic genes are downregulated in a patient with melanoma and repeated in-transit metastases.

Salemi M, Giuffrida D, Soma PF, Giuffrida MC, Galia A, Calogero AE.

Am J Dermatopathol. 2012 Jun;34(4):454-5. doi: 10.1097/DAD.0b013e31820a4bd7. No abstract available.

PMID:
21986234
5.

PARP1 and CASP3 gene expression in a patient with multiple head and neck squamous cell carcinoma and Parkinson disease.

Calogero AE, Soma PF, Giuffrida MC, Giuffrida D, La Vignera S, Romano C, Castiglione R, Bosco P, Salemi M.

Hum Cell. 2013 Mar;26(1):44-6. doi: 10.1007/s13577-011-0021-4. Epub 2011 Jun 5. No abstract available.

PMID:
21644054
6.

Over expression of LDOC1 and PARP1, two pro-apoptotic genes, in a patient with cryptorchidism and DiGeorge anomaly.

Salemi M, Castiglione R, La Vignera S, Condorelli RA, Bosco P, Vicari E, Calogero AE.

Hum Cell. 2011 Jun;24(2):112-3. doi: 10.1007/s13577-011-0015-2. Epub 2011 Mar 4. No abstract available.

PMID:
21547351
7.

[The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].

Song Y, Shen K, Yu JR.

Zhonghua Yi Xue Za Zhi. 2007 Nov 6;87(41):2919-24. Chinese.

PMID:
18261307
8.

CASP3 protein expression by flow cytometry in Down's syndrome subjects.

Salemi M, Condorelli RA, Romano C, Concetta B, Romano C, Salluzzo MG, Bosco P, Calogero AE.

Hum Cell. 2014 Jan;27(1):43-5. doi: 10.1007/s13577-013-0071-x. Epub 2013 Dec 13.

PMID:
24338704
9.

PARP-1 and CASP3 genes are up-regulated in LNCaP and PC-3 prostate cancer cell lines.

Salemi M, Condorelli RA, La Vignera S, Barone N, Ridolfo F, Giuffrida MC, Vicari E, Calogero AE.

Hum Cell. 2014 Oct;27(4):172-5. doi: 10.1007/s13577-013-0076-5. Epub 2014 Jul 19. No abstract available.

PMID:
25037599
10.

Heterogeneous nuclear ribonucleoprotein U-like 1 and Poly (ADP-ribose) polymerase 1 are downregulated in renal cell carcinoma and connected with the prognosis.

Xu T, Zou Q, Wu J, Yu B, Xu Z, Cai H, Zhang W.

Cancer Biomark. 2013 Jan 1;13(6):411-5. doi: 10.3233/CBM-140390.

PMID:
24595077
11.

MYC, PARP1, and chemoresistance: BIN there, done that?

Ganesan S.

Sci Signal. 2011 Mar 29;4(166):pe15. doi: 10.1126/scisignal.2001946. Review.

PMID:
21447796
12.

Caspase gene expression in the brain as a function of the clinical progression of Alzheimer disease.

Pompl PN, Yemul S, Xiang Z, Ho L, Haroutunian V, Purohit D, Mohs R, Pasinetti GM.

Arch Neurol. 2003 Mar;60(3):369-76.

PMID:
12633148
13.

[c-MYC, PARP1 and BIN1 as targets for therapy of cancer cell resistance].

Pyndiah S, Sakamuro D.

Med Sci (Paris). 2013 Feb;29(2):133-5. doi: 10.1051/medsci/2013292006. Epub 2013 Feb 28. French. No abstract available.

14.

A functional variant at the miR-885-5p binding site of CASP3 confers risk of both index and second primary malignancies in patients with head and neck cancer.

Guan X, Liu Z, Liu H, Yu H, Wang LE, Sturgis EM, Li G, Wei Q.

FASEB J. 2013 Apr;27(4):1404-12. doi: 10.1096/fj.12-223420. Epub 2012 Dec 27.

15.

Evaluation of the poly(ADP-ribose) polymerase-1 gene variants in Alzheimer's disease.

Liu HP, Lin WY, Wu BT, Liu SH, Wang WF, Tsai CH, Lee CC, Tsai FJ.

J Clin Lab Anal. 2010;24(3):182-6. doi: 10.1002/jcla.20379.

PMID:
20486200
16.

Interaction between poly(ADP-ribose) polymerase 1 and interleukin 1A genes is associated with Alzheimer's disease risk.

Infante J, Llorca J, Mateo I, Rodríguez-Rodríguez E, Sánchez-Quintana C, Sánchez-Juan P, Fernández-Viadero C, Peña N, Berciano J, Combarros O.

Dement Geriatr Cogn Disord. 2007;23(4):215-8. Epub 2007 Feb 9.

PMID:
17290104
17.
18.

Variations in the mRNA expression of poly(ADP-ribose) polymerases, poly(ADP-ribose) glycohydrolase and ADP-ribosylhydrolase 3 in breast tumors and impact on clinical outcome.

Bieche I, Pennaneach V, Driouch K, Vacher S, Zaremba T, Susini A, Lidereau R, Hall J.

Int J Cancer. 2013 Dec 15;133(12):2791-800. doi: 10.1002/ijc.28304. Epub 2013 Aug 9.

19.

Hippocampal poly(ADP-Ribose) polymerase 1 and caspase 3 activation in neonatal bornavirus infection.

Williams BL, Hornig M, Yaddanapudi K, Lipkin WI.

J Virol. 2008 Feb;82(4):1748-58. Epub 2007 Dec 5.

20.

Rapamycin-resistant poly (ADP-ribose) polymerase-1 overexpression is a potential therapeutic target in lymphangioleiomyomatosis.

Sun Y, Gallacchi D, Zhang EY, Reynolds SB, Robinson L, Malinowska IA, Chiou TT, Pereira AM, Li C, Kwiatkowski DJ, Lee PS, Yu JJ.

Am J Respir Cell Mol Biol. 2014 Dec;51(6):738-49. doi: 10.1165/rcmb.2014-0033OC.

Supplemental Content

Support Center